Listening to patient-reported outcomes, especially in clinical trials, is extremely important, especially the array of technology available to collect this information, said Sophia K. Smith, PhD, MSW, associate professor at the Duke School of Nursing.
Listening to patient-reported outcomes, especially in clinical trials, is extremely important, especially the array of technology available to collect this information, said Sophia K. Smith, PhD, MSW, associate professor at the Duke School of Nursing.
Transcript (modified)
Can the introduction of patient-centeredness in clinical trials, such as measures of patient-reported outcomes (PROs), be considered palliative care?
I’m a big proponent of hearing from the patient. I think PROs are extremely important, particularly in clinical trials. There’s different ways to collect this information. I think that we should really look at technology to help leverage that with electronic patient-reported outcomes systems
I know that a lot of our medical systems have electronic health records now, such as Epic, and they actually have survey capability built in. There’s other tools such as Apple Research Kit, where we can provide surveys on mobile devices, so a lot of our patients, particularly our younger patients and our patients who may use their smartphone as their only connection to the internet, being able to put these PROs out there for them to use on their mobile devices is really important.
I am also a big proponent of the distress thermometers, so you could probably characterize that as a PRO, but each time our cancer patients come in for their treatment or a visit we ask them how distressed they are and then we list a series of areas that they might be distressed in. For example, financial distress, emotional distress, maybe relationship problems, maybe some spiritual crisis. So that’s another form of PROs and, again, as early in the process as you can introduce these things the better.
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More